Dorameda - Company finances
|
EUR
|
2020
From: 2020-07-17
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | 58,005 | 11,197 | 7,257 | 15,109 | 2,400 | 29,899 |
| Profit before tax | 39,136 | -14,180 | -6,643 | -6,625 | -2,890 | -1,609 |
| Net profit | 39,136 | -14,180 | -6,643 | -6,625 | -2,890 | -1,609 |
| Equity | 39,136 | 24,956 | 18,312 | 11,687 | 8,797 | 7,189 |
| Liabilities | - | - | 8,078 | 7,893 | 7,745 | 9,958 |
| Non-current assets | 1,557 | 1,133 | 744 | 319 | 1 | 1 |
| Current assets | 38,307 | 31,693 | 25,646 | 19,261 | 16,541 | 17,146 |
| Total assets | 39,864 | 32,826 | 26,390 | 19,580 | 16,542 | 17,147 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | 221 | - | - |
|
Financial indicators
|
||||||
| Revenue change y/y | - | -80.7% | -35.2% | +108.2% | -84.1% | +1145.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 98.2% | -43.2% | -25.2% | -33.8% | -17.5% | -9.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 100.0% | -56.8% | -36.3% | -56.7% | -32.9% | -22.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 67.5% | -126.6% | -91.5% | -43.8% | -120.4% | -5.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 67.5% | -126.6% | -91.5% | -43.8% | -120.4% | -5.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.4 | 0.7 | 0.9 | 1.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dorameda - Social security debts
The amount of overdue SODRA debt for the company Dorameda as of the last working day is: 241 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-14 | 241.44 |
| 2026-09-01 | 2026-09-02 | 241.44 |
| 2026-08-26 | 2026-08-31 | 160.96 |
| 2026-08-23 | 2026-08-23 | 160.96 |
| 2026-08-19 | 2026-08-19 | 160.96 |
| 2026-08-16 | 2026-08-17 | 160.96 |
| 2026-08-01 | 2026-08-14 | 160.96 |
| 2026-07-01 | 2026-07-31 | 80.48 |
| 2026-06-02 | 2026-06-18 | 160.96 |
| 2026-05-03 | 2026-06-01 | 80.48 |
| 2026-04-01 | 2026-04-30 | 164.72 |
| 2026-03-03 | 2026-03-31 | 84.24 |
| 2026-02-03 | 2026-03-02 | 3.76 |
| 2025-09-02 | 2025-09-30 | 68.18 |
| 2025-01-02 | 2025-01-05 | 363.61 |
| 2024-12-03 | 2024-12-31 | 299.11 |
| 2024-11-20 | 2024-12-02 | 234.61 |
| 2024-11-04 | 2024-11-19 | 323.84 |
| 2024-10-01 | 2024-11-03 | 259.34 |
| 2024-09-03 | 2024-09-30 | 194.84 |
| 2024-08-23 | 2024-09-02 | 130.34 |
| 2024-08-01 | 2024-08-22 | 613.34 |
| 2024-07-15 | 2024-07-31 | 548.84 |
| 2024-07-02 | 2024-07-14 | 665.15 |
| 2024-06-03 | 2024-07-01 | 600.65 |
| 2024-05-15 | 2024-06-02 | 536.15 |
| 2024-05-02 | 2024-05-14 | 49.97 |
| 2024-04-03 | 2024-04-30 | 185.47 |
| 2024-03-15 | 2024-04-02 | 120.97 |
| 2024-03-01 | 2024-03-14 | 129.00 |
| 2024-02-01 | 2024-02-29 | 64.50 |
| 2024-01-03 | 2024-01-29 | 117.26 |
| 2023-12-01 | 2024-01-02 | 58.63 |
| 2023-11-21 | 2023-11-30 | 167.15 |
| 2023-11-03 | 2023-11-20 | 175.89 |
| 2023-10-03 | 2023-11-02 | 117.26 |
| 2023-09-01 | 2023-10-02 | 58.63 |
| 2023-08-01 | 2023-08-27 | 234.52 |
| 2023-07-03 | 2023-07-31 | 175.89 |
| 2023-06-01 | 2023-07-02 | 117.26 |
| 2023-05-04 | 2023-05-31 | 58.63 |
| 2023-04-03 | 2023-04-30 | 175.89 |
| 2023-03-01 | 2023-04-02 | 117.26 |
| 2023-02-07 | 2023-02-28 | 58.63 |
| 2023-02-01 | 2023-02-06 | 160.53 |
| 2023-01-03 | 2023-01-31 | 101.90 |
| 2022-12-01 | 2023-01-02 | 50.95 |
| 2022-11-03 | 2022-11-30 | 101.90 |
| 2022-10-03 | 2022-11-02 | 50.95 |
| 2022-09-01 | 2022-09-30 | 50.95 |
| 2022-08-02 | 2022-08-31 | 101.90 |
| 2022-06-01 | 2022-08-01 | 50.95 |
| 2022-05-03 | 2022-05-31 | 4.06 |
Dorameda - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dorameda, MB (code 305591318) is a Small partnership engaged in repair and renovation of buildings. In 2025, the company generated revenue of €29.9K and reported a net loss of €1.6K, resulting in a negative profit margin of -5.4%. Performance improved materially from 2024, when revenue was only €2.4K and the business posted a €2.9K loss, after a 2023 result of €15.1K in revenue and a €6.6K loss. The 2025 revenue increase was strong, reflecting recovery from the low 2024 base, while losses narrowed as turnover expanded. At the end of 2025, total assets stood at €17.1K, equity at €7.2K and liabilities at €10.0K. The equity ratio was 41.9%, debt-to-equity was 1.39, asset turnover was 1.74x, ROE was -22.4% and ROA was -9.4%. No staff data is provided, so revenue per employee cannot be assessed.